Market Place
Sourcing Support
Avanir files WARN notice for 100+ layoffs from California
04 Nov 2022 //
ENDPTS
US layoffs for Avanir, Strides; Sanofi to cut force in Korea
02 Nov 2022 //
FIERCEPHARMA
Avanir Pharmaceuticals Joins California Life Sciences
28 Jul 2021 //
PRNEWSWIRE
University of California Irvine`s Paul Merage School of Business Avanir Pharma
16 Jun 2020 //
PRNEWSWIRE
Otsuka`s Avanir unit plots 140 layoffs in wake of $116M Nuedexta settlement
11 Jan 2020 //
FIERCE PHARMA
Otsuka presses on with Alzheimer’s agitation drug
12 Nov 2019 //
PMLIVE
Avanir Pharma to Continue Clinical Development of Investigational AVP-786
12 Nov 2019 //
PR NEWSWIRE
Avanir’s week goes from bad to worse with Alzheimer’s stumble
02 Oct 2019 //
PMLIVE
Reeling from a hefty civil and criminal settlement
30 Sep 2019 //
ENDPTS
Otsuka, China`s bidding, Aurobindo and more—FiercePharmaAsia
27 Sep 2019 //
FIERCE PHARMA
Avanir agrees to pay $108M over Neudexta kickbacks probe
27 Sep 2019 //
FIERCE PHARMA
Avanir cites ‘encouraging’ progress in PhIII program for Alzheimer’s agitation
26 Mar 2019 //
ENDPTS
Otsuka expects to pay $120M to wrap the feds` Nuedexta probe
15 Feb 2019 //
FIERCE PHARMA
Medicare alert draws attention to use of laughing drug Nuedexta
04 Jun 2018 //
FIERCE PHARMA
Avanir lays off dozens of sales rep amid probe into its key drug
06 Dec 2017 //
STATNEWS
Did Avanir overmarket its brain drug to the elderly?
13 Oct 2017 //
FIERCE PHARMA
Avanir Pharmaceuticals to Present Data on NUEDEXTA & ONZETRA® Xsail
19 Apr 2017 //
PR NEWSWIRE
Avanir shelves Danny Glover PBA awareness ad in favor of branded Nuedexta effort
21 Dec 2016 //
FIERCE PHARMA
Avanir Appoints Richard, as Senior Vice President, Research & Development, & CMO
29 Nov 2016 //
PR NEWSWIRE
Avanir Pharmaceuticals to Present Data on ONZETRA™ Xsail™ at AHS 2016
09 Jun 2016 //
PR NEWSWIRE
NUEDEXTA Effective for Pseudobulbar Affect in Patients with Alzheimer`s Disease
08 Jun 2016 //
PR NEWSWIRE
Avanir Announces FDA Approval of ONZETRA™ Xsail™for Treatment of Migraine
28 Jan 2016 //
MULTIVU
AVANIR Taps New CEO with Commitment to Create A Multi-Product CNS Company
26 Jan 2016 //
BIOSPACE
AVANIR (AVNR) Names a New CEO
20 Jan 2016 //
PR NEWSWIRE
Concert Pharma`s CF drug tops Vertex`s top-seller in early study
24 Sep 2015 //
FIERCE BIOTECH
Otsuka faces the music for generic Abilify, loses battle with FDA
30 May 2015 //
FIERCE PHARMA
Activists Ready to Fight for Ariad CEO`s Ouster: CNBC
13 Feb 2015 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.